View Past PerformanceCBD Life Sciences 대차대조표 건전성재무 건전성 기준 점검 0/6CBD Life Sciences 의 상태를 파악하기에는 데이터가 부족합니다.핵심 정보n/a부채/자본 비율n/a부채이자보상배율n/a현금n/a자본n/a총부채n/a총자산n/a최근 재무 건전성 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0공시 • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.공시 • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.공시 • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.공시 • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.공시 • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.공시 • Sep 18CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused with Mushroom Extracts, Set to Drive Revenue and Revolutionize WellnessCBD Life Sciences Inc. launched a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system. Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being. Unrivaled Benefits of Key Ingredients: Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today. Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity. Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery. Revenue Projections & Market Potential.With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences Inc.'s annual revenue. Analystsexpect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.공시 • Sep 05CBD Life Sciences Inc. Unveils Mellow MorningsCBD Life Sciences Inc. announced the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to daily coffee routine. Riding the Wave of a Growing Market: The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD. Significant Revenue Potential: Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country. Revolutionary CBD Delivery for Maximum Efficacy: Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market. Adoption by Local Coffee Shops: Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.공시 • Jul 10CBD Life Sciences Inc. Through Its Wholly Owned Subsidiary, The CBD Vault Inc. Launches New Line of Kava & Kratom ShotsCBD Life Sciences Inc. through its wholly owned subsidiary, The CBD Vault Inc. announced the launch of its new line of Kava & Kratom shots. Designed to provide a natural boost of energy and relaxation, these shots are the latest addition to the company's innovative product lineup. Product Highlights: Natural Ingredients: Kava & Kratom shots are crafted using the highest quality natural ingredients, ensuring a safe and effective experience. Convenient & Portable: Packaged in a sleek, portable bottle, these shots are perfect for on-the-go use, making it easy to enjoy their benefits anytime, anywhere. Balanced Formulation: The carefully balanced blend of Kava and Kratom provides a harmonious mix of relaxation and energy, helping stay focused and calm throughout the day. Great Taste: Available in a delicious apple flavor, shots are as enjoyable to drink as they are effective. Kava and Kratom are two powerful botanicals known for their unique properties. Kava, traditionally used in Pacific Island cultures, is renowned for its calming effects, while Kratom, native to Southeast Asia, is celebrated for its stimulating and pain-relieving properties. Together, they offer a synergistic effect that supports both mental and physical well-being.공시 • May 03CBD Life Sciences Inc. has filed a Follow-on Equity Offering.CBD Life Sciences Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,000,000,000공시 • Jan 12CBD Life Sciences Inc. Launches Premium Terpene Infused OilCBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announced that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc.'s website. LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience's all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC's new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.재무 상태 분석단기부채: CBDL 의 단기 자산이 단기 부채를 감당하는지 판단하기에는 데이터가 부족합니다.장기 부채: CBDL의 단기 자산이 장기 부채를 충당하는지 판단하기에 데이터가 부족합니다.부채/자본 비율 추이 및 분석부채 수준: satisfactory인지 판단하기 위해 CBDL 의 순 부채 대 자기자본 비율을 계산하기에는 데이터가 부족합니다.부채 감소: 지난 5년 동안 CBDL의 부채 대비 자본 비율이 감소했는지 판단하기에 데이터가 부족합니다.부채 범위: CBDL 의 부채가 영업 현금 흐름에 의해 잘 충당되었는지 판단하기에는 데이터가 부족합니다.이자 보장: CBDL 의 부채에 대한 이자 지급이 EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.대차대조표건전한 기업 찾아보기7D1Y7D1Y7D1YPharmaceuticals-biotech 산업의 건실한 기업.View Dividend기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 01:55종가2026/05/22 00:00수익2024/03/31연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스CBD Life Sciences Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0
공시 • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.
공시 • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.
공시 • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.
공시 • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.
공시 • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.
공시 • Sep 18CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused with Mushroom Extracts, Set to Drive Revenue and Revolutionize WellnessCBD Life Sciences Inc. launched a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system. Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being. Unrivaled Benefits of Key Ingredients: Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today. Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity. Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery. Revenue Projections & Market Potential.With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences Inc.'s annual revenue. Analystsexpect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.
공시 • Sep 05CBD Life Sciences Inc. Unveils Mellow MorningsCBD Life Sciences Inc. announced the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to daily coffee routine. Riding the Wave of a Growing Market: The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD. Significant Revenue Potential: Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country. Revolutionary CBD Delivery for Maximum Efficacy: Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market. Adoption by Local Coffee Shops: Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.
공시 • Jul 10CBD Life Sciences Inc. Through Its Wholly Owned Subsidiary, The CBD Vault Inc. Launches New Line of Kava & Kratom ShotsCBD Life Sciences Inc. through its wholly owned subsidiary, The CBD Vault Inc. announced the launch of its new line of Kava & Kratom shots. Designed to provide a natural boost of energy and relaxation, these shots are the latest addition to the company's innovative product lineup. Product Highlights: Natural Ingredients: Kava & Kratom shots are crafted using the highest quality natural ingredients, ensuring a safe and effective experience. Convenient & Portable: Packaged in a sleek, portable bottle, these shots are perfect for on-the-go use, making it easy to enjoy their benefits anytime, anywhere. Balanced Formulation: The carefully balanced blend of Kava and Kratom provides a harmonious mix of relaxation and energy, helping stay focused and calm throughout the day. Great Taste: Available in a delicious apple flavor, shots are as enjoyable to drink as they are effective. Kava and Kratom are two powerful botanicals known for their unique properties. Kava, traditionally used in Pacific Island cultures, is renowned for its calming effects, while Kratom, native to Southeast Asia, is celebrated for its stimulating and pain-relieving properties. Together, they offer a synergistic effect that supports both mental and physical well-being.
공시 • May 03CBD Life Sciences Inc. has filed a Follow-on Equity Offering.CBD Life Sciences Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,000,000,000
공시 • Jan 12CBD Life Sciences Inc. Launches Premium Terpene Infused OilCBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announced that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc.'s website. LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience's all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC's new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.